Health & Medicine

Hydroxycarbamide Approved for Sickle Cell Disease

Hydroxycarbamide, also known as hydroxyurea, was approved by the FDA as the first preventive treatment for patients suffering from sickle cell disease. This groundbreaking medication was developed to reduce the frequency of painful crises and the need for blood transfusions by increasing fetal hemoglobin levels in the blood. The approval came after extensive clinical trials demonstrating its effectiveness and safety profile in the treatment of this hereditary blood disorder, which primarily affects individuals of African descent.

Continue Reading